Related Experiment Video
Updated: Jun 10, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Reversible posterior leukoencephalopathy induced by cancer chemotherapy
Birol Baytan1, Ozlem Ozdemir, Metin Demirkaya
1Department of Pediatric Hematology, Uludag University Medical Faculty, Görükle Bursa, Turkey. birolbaytan@yahoo.com
Insights
Reversible posterior leukoencephalopathy (RPLS) can affect children undergoing chemotherapy, causing neurological symptoms and characteristic MRI findings. Prompt diagnosis is crucial for patients presenting with hypertension and neurological issues during cancer treatment.
Area of Science:
- Neurology
- Pediatric Oncology
- Radiology
Background:
- Reversible posterior leukoencephalopathy (RPLS) is a neurological condition.
- It is increasingly recognized in children undergoing chemotherapy.
Observation:
- The syndrome presents with hypertension, altered mental status, seizures, hallucinations, and visual disturbances.
- Neuroimaging reveals symmetric white matter lesions, predominantly in the parietal and occipital lobes.
Findings:
- This study presents four cases of chemotherapy-induced RPLS.
- The exact etiology of RPLS remains unknown, but chemotherapy is a potential trigger.
Implications:
- Consider RPLS in pediatric cancer patients with sudden hypertension and neurological complications, particularly seizures.
- Early recognition and diagnosis are vital for managing this potentially reversible condition.
Abstract:
Reversible posterior leukoencephalopathy, defined by both clinical and neuroimaging findings, can affect children receiving chemotherapy. The syndrome is characterized by hypertension, alterations in mental status, seizures, hallucinations, and acute visual changes and is associated with abnormalities seen in magnetic resonance imaging of symmetric white matter lesions, especially in the parietal and occipital lobes. The etiology of reversible posterior leukoencephalopathy is as yet unknown. Presented here are four cases of reversible posterior leukoencephalopathy induced by chemotherapy, with a brief review of the literature and consideration of possible mechanisms. A diagnosis of reversible posterior leukoencephalopathy should be considered when patients receiving cancer chemotherapy suddenly develop hypertension followed by neurologic complications, especially if presenting with seizures.
Related Concept Videos
Hepatic Encephalopathy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Treatment Resistent Cancers
Cryptococcal Meningitis
Encephalitis l: Introduction
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
Phenothiazines, such as prochlorperazine...

